Phase I study of Adva 27a for use in patients with multidrug-resistant breast cancer

Trial Profile

Phase I study of Adva 27a for use in patients with multidrug-resistant breast cancer

Planning
Phase of Trial: Phase I

Latest Information Update: 25 Feb 2015

At a glance

  • Drugs Adva 27a (Primary)
  • Indications Breast cancer
  • Focus Adverse reactions
  • Sponsors Sunshine Biopharma
  • Most Recent Events

    • 25 Feb 2015 This trial is still in the planning stage, according to a Sunshine Biopharma media release.
    • 13 Sep 2012 This trial is still in the planning stages, according to a Sunshine Biopharma media release.
    • 14 Oct 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top